Trials / Unknown
UnknownNCT05626504
Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- King's College Hospital NHS Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this project the investigators study the safety and efficacy of the pipeline embolization device with vantage technology in treatment of unruptured brain aneurysms
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pipeline Embolization Device with Vantage Technology | Flow-diverter device occludes aneurysms through endoluminal reconstruction and remodelling of the parent artery. |
Timeline
- Start date
- 2022-10-27
- Primary completion
- 2025-03-01
- Completion
- 2025-03-31
- First posted
- 2022-11-23
- Last updated
- 2024-03-05
Locations
1 site across 1 country: United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05626504. Inclusion in this directory is not an endorsement.